Shares of Cartier owner Richemont jump 7% as shoppers splurge on jewelry despite luxury slowdown

Shares of Cartier owner Richemont jump 7% as shoppers splurge on jewelry despite luxury slowdown


A Cartier de Panthere wristwatch on display at a Cartier luxury goods store, operated by Cie. Financiere Richemont.

Bloomberg | Getty Images

Cartier owner Richemont on Friday posted better-than-expected fiscal fourth-quarter sales, as the wealthiest spenders continued to shrug off global macroeconomic uncertainty.

Revenues at the Swiss luxury group rose 7% year-on-year at constant exchange rates to 5.17 billion euros ($5.79 billion) in the three months to the end of March, above the 4.98 billion euros forecast by analysts in an LSEG poll.

Shares were up 7.1% by 9:54 a.m. London time to trade at the top of the Stoxx 600.

The fourth-quarter sales bump was led by double-digit growth at the group’s Jewellery Maisons division, which includes Cartier, Van Cleef & Arpels and Buccellati.

Sales nevertheless declined within the company’s specialist watchmakers segment, which features brands Piaget and Roger Dubuis, led by weakness in the Asia-Pacific region.

Full-year sales rose 4% to 21.4 billion euros, up on the previous year and just ahead of analyst expectations of 21.34 billion euros.

Sales rose annually across all regions, except Asia Pacific (ex. Japan) — the company’s largest market — where declines were led by a 23% drop in China. Japan led annual sales growth, up 25% at actual exchange rates, buoyed by “strong domestic and tourist spend” and a weak Japanese Yen.

“The Group’s performance was robust overall, driven by remarkable growth at our Jewellery Maisons and retail, and improved momentum at our ‘Other’ activities,” Richemont Chairman Johann Rupert said in a statement. The company’s so-called “other” segment includes its pre-owned watch retailer Watchfinder & Co.

The chairman nevertheless added that ongoing global uncertainties would continue to require “strong agility and discipline.”

BofA Global Research said in a note last week that Richemont faces three key global headwinds: gold prices, U.S. tariffs and foreign exchange fluctuations, by way of the strength of the Swiss Franc and the weakness of the U.S. dollar.

However, the bank’s analysts added that the company’s pricing power could provide a tailwind.

“We think price will cover half the headwinds,” they wrote. “Pricing, product mix and higher capacity utilization are the most obvious offsets.”

Richemont had previously reported its “highest ever” quarterly sales figure in January at 6.2 billion euros, even as China demand weighed.

The earnings had, at the time, been taken as a signal of a wider turnaround in the beleaguered luxury sector. However, the specter of U.S. trade tariffs and subsequent macroeconomic uncertainty have threatened to once again hit consumer confidence and discretionary spending globally.

This is a developing story, please check back for updates.



Source

German inflation dips to cooler-than-expected 1.8% in July
World

German inflation dips to cooler-than-expected 1.8% in July

Rhineland-Palatinate, Mainz: Fruit is sold at the weekly market. Andreas Arnold/dpa | Picture Alliance | Getty Images German inflation fell more than expected to 1.8% in July, data from statistics agency Destatis showed Thursday. Economists polled by Reuters had anticipated inflation to dip to 1.9%. July’s reading compares to the 2% print recorded in June, […]

Read More
CNBC’s Inside India newsletter: Why an India-U.K. trade deal does not make U.S.-India agreement any easier
World

CNBC’s Inside India newsletter: Why an India-U.K. trade deal does not make U.S.-India agreement any easier

CNBC reporter Ganesh Rao with India Commerce Secretary Piyush Goyal © George Bextor, CNBC Hello, this is Ganesh Rao, CNBC’s senior correspondent, writing from London. This week, I look into India’s willingness and limitations to strike trade deals after I sat down with the country’s Commerce Secretary Piyush Goyal. Enjoy! This report is from this […]

Read More
Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow
World

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine market.  […]

Read More